Unresectable Metastatic Colorectal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-08-18
Clinical Trial Update: A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy [Phase 2]
A Phase II study evaluating fruquintinib in combination with capecitabine as first-line therapy for advanced/metastatic colorectal cancer un…
CLINICAL_TRIALS trial_result · 2021-10-20
Clinical Trial Update: A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx [Phase 2]
Phase 2 clinical trial comparing AK105 plus Anlotinib and CapeOx regimens in unresectable metastatic colorectal cancer; status currently UNK…